FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

ANTHEM BIOSCIENCES LTD.

NSE : ANTHEMBSE : 544449ISIN CODE : INE0CZ201020Industry : Pharmaceuticals & DrugsHouse : Private

BSE756.40-0.8 (-0.11 %)

PREV CLOSE (Rs.) 757.20

OPEN PRICE (Rs.) 752.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 254470

TODAY'S LOW / HIGH (Rs.)737.10 762.80

52 WK LOW / HIGH (Rs.)701.75 770

NSE757.35-0.95 (-0.13 %)

PREV CLOSE( Rs. ) 758.30

OPEN PRICE (Rs.) 753.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 757.35 (60826)

VOLUME 3115418

TODAY'S LOW / HIGH(Rs.) 737.30 762.70

52 WK LOW / HIGH (Rs.)701.9 770

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

1908.71

Dividend Yield(%)

0.00

TTM EPS (Rs.)

9.01

P/E Ratio

83.92

Book Value (Rs.)

104.13

Face Value (Rs.)

MCap (Rs. in Mn)

424801.84

Price/Earning (TTM)

72.72

Price/Sales (TTM)

23.08

Price/Book (MRQ)

7.26

PAT Margin (%)

27.50

ROCE (%)

30.79

Incorporation Year : 13-06 2006

Management Info :

Ajay Bhardwaj - Chairman Ajay Bhardwaj - Managing Director

Registered Office :

Address : No. 49, F1 & F2, Canara Bank Road,Bommasandra Industrial Area,Phase I, Bommasandra,
Bengaluru,
Karnataka-560099

Phone : 080-66724000

Email : investors.abl@anthembio.com

Website : www.anthembio.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

21Jul Anthem Biosciences lists with 27% prem
Anthem Biosciences has debuted at Rs 723.10 on the BSE, up by 153.1 poin..

17Jul New Listing
Notice No. 20250718-44 Notice Date 18 Jul 2025Category Company r..

11Jul Anthem Biosciences coming with IPO to
Anthem BiosciencesAnthem Biosciences is coming out with a 100% book buil..

Financials

	QTR	ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)

3602.50 (2.46%)

M.Cap (Rs. in Cr)121924.97

Pfizer (BSE)

5354.75 (1.23%)

M.Cap (Rs. in Cr)24496.77

Cipla (BSE)

1531.10 (2.95%)

M.Cap (Rs. in Cr)123674.79

Solara Active Pharma (BSE)

695.80 (5.85%)

M.Cap (Rs. in Cr)3350.49

Shareholding Pattern

	PROMOTERS	76.84%
	NON-INSTITUTION	23.16%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22